Comments
Loading...
Arvinas (NASDAQ:ARVN) Stock Quotes, Forecast and News Summary
Arvinas Stock (NASDAQ: ARVN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Arvinas (ARVN) stock?
You can purchase shares of Arvinas (NASDAQ:ARVN) through any online brokerage.
Who are Arvinas (ARVN) competitors?
Other companies in Arvinas’s space includes: WAVE Life Sciences (NASDAQ:WVE), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), Phibro Animal Health (NASDAQ:PAHC) and Neumora Therapeutics (NASDAQ:NMRA).
What is the forecast, or price target, for Arvinas (ARVN) stock?
Arvinas has a consensus price target of $61.21.
What is the current price for Arvinas (ARVN)?
The stock price for Arvinas (NASDAQ: ARVN) is $24.87 last updated November 21, 2024 at 1:12 PM EST.
Does Arvinas (ARVN) pay a dividend?
There are no upcoming dividends for Arvinas.
When is Arvinas (NASDAQ:ARVN) reporting earnings?
Arvinas’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
Is Arvinas (ARVN) going to split?
There is no upcoming split for Arvinas.
What sector and industry does Arvinas (ARVN) operate in?
Arvinas is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.